Anna Veiga Lluch
Biologist
She is director of the Barcelona Cell Line Bank and head of the research group on advanced cell therapies with pluripotent stem cells in the Regenerative Medicine Programme P -CMR[C], at the Bellvitge Biomedical Research Institute (IDIBELL), director of the Probitas Foundation and associate professor in the Department of Health and Life Sciences at Pompeu Fabra University (UPF). Her areas of expertise are clinical embryology, reproductive genetics, stem cells, cell therapy and bioethics.